MDRX
Veradigm Inc.
Price Chart
Latest Quote
$4.74
+0.14 (+3.04%)
Current Price
| Previous Close | $4.60 |
| Open | $4.80 |
| Day High | $4.89 |
| Day Low | $4.80 |
| Volume | 9,961 |
Stock Information
| Shares Outstanding | 108.99M |
| Total Debt | $218.81M |
| Cash Equivalents | $492.60M |
| Revenue | $594.41M |
| Net Income | $-291.54M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $516.62M |
| EPS (TTM) | $-2.73 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $271.16M |
| Sales | $594.41M |
| Income | $-291.54M |
| Book/sh | $7.43 |
| Cash/sh | $4.52 |
| Employees | 2K |
Financial Ratios
| Quick Ratio | 1.17 |
| Current Ratio | 1.29 |
| Debt/Eq | 18.59 |
| EPS Growth TTM | -10.20% |
Returns & Margins
| ROA | -3.69% |
| ROE | -31.05% |
| Gross Margin | 50.85% |
| Operating Margin | 16.59% |
| Profit Margin | -49.05% |
Ownership
| Insider Ownership | 4.43% |
| Institutional Ownership | 66.00% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 15.80 |
| PEG | 1.95 |
| P/S | 0.87 |
| P/B | 0.64 |
Analyst Data
| Recommendation | buy |
| Target Price | $6.50 |
Technical Indicators
| SMA20 | $4.93 |
| SMA50 | $4.74 |
| SMA200 | $4.69 |
| RSI | 58.87 |
| ATR | 0.3764 |
| Shares Float | 52.13M |
| Short Ratio | 3.92 |
| Volatility | 0.54 |
| Rel Volume | 4.48 |
Performance History
| Week | +4.17% |
| Month | +5.26% |
| Quarter | +8.70% |
| 6 Months | +3.52% |
| YTD | +9.89% |
| Year | +11.36% |
| 3 Years | -57.01% |
| 5 Years | -71.77% |
| 10 Years | -57.91% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $5.00 | 426,200 |
| 2026-06-23 | $4.95 | 5,600 |
| 2026-06-22 | $5.00 | 3,400 |
| 2026-06-18 | $4.80 | 2,000 |
| 2026-06-17 | $4.80 | 3,400 |
| 2026-06-16 | $4.80 | 1,000 |
| 2026-06-15 | $4.85 | 2,100 |
| 2026-06-12 | $4.80 | 21,600 |
| 2026-06-11 | $5.18 | 800 |
| 2026-06-10 | $5.10 | 22,700 |
| 2026-06-09 | $5.10 | 14,400 |
| 2026-06-08 | $5.10 | 15,800 |
| 2026-06-05 | $5.00 | 27,200 |
| 2026-06-04 | $5.10 | 149,500 |
| 2026-06-03 | $4.75 | 876,900 |
| 2026-06-02 | $4.50 | 13,200 |
| 2026-06-01 | $4.90 | 1,500 |
| 2026-05-29 | $5.00 | 99,600 |
| 2026-05-28 | $4.90 | 60,200 |
| 2026-05-27 | $4.90 | 156,000 |
| 2026-05-26 | $4.75 | 18,900 |
About Veradigm Inc.
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include eprescribe with EPCS, EHR software, veradigm EHR, and practice fusion EHR; and patient engagement platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as veradigm connect, veradigm app expo, and diagnostic ordering and resulting network; life sciences, health plans and payers, and providers; and veradigm eprescribe enterprise. In addition, the company offers risk adjustment solutions, such as health equity analytics, risk adjustment analytics, risk mitigator, comprehensive submissions, and utilization analytics; quality analytics, risk adjustment, and quality management; clinical data exchange and coding solutions, including echart courier, echart coder, and echart integration and analytics; clinical data registries for physicians and veradigm payer insights; provider engagement solutions; care gap alerting, gap closure services, and veradigm payerpath solutions. Further, it provides real world data solutions, such as NLP-enriched EHR data solutions, and clinical data registries; real world evidence and real-world evidence analytics platform; and digital health media solutions. Additionally, the company serves physician practices, hospitals, laboratory and radiology centers, urgent care facilities, health IT companies. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
đ° Latest News
Veradigm names CFO as it works to get current on financial filings
Healthcare Dive âĸ 2026-04-07T11:32:00Z
Veradigm avoids enforcement action in SEC probe
Healthcare Dive âĸ 2026-02-25T10:25:07Z
Veradigm cut 15% of its workforce in 2025
Healthcare Dive âĸ 2026-02-19T09:10:30Z
Private Markets: Muskâs SpaceX targets 2026 IPO at valuation of $1.5T
TipRanks âĸ 2025-12-13T16:35:52Z
States are ramping up AI regulation. How should healthcare respond?
Healthcare Dive âĸ 2025-09-23T09:52:59Z
Veradigm appoints new CEO
Healthcare Dive âĸ 2025-08-19T10:04:48Z
Oracle Unveils AI EHR to Accelerate Cloud Growth and Healthcare Reach
Zacks âĸ 2025-08-15T13:05:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2022-12-31 | 2021-12-31 |
|---|---|---|
| Revenue | ||
| Reconciled Cost Of Revenue | $224,560,000 | $231,488,000 |
| Cost Of Revenue | $279,597,000 | $294,981,000 |
| Total Revenue | $588,017,000 | $577,427,000 |
| Operating Revenue | $588,017,000 | $577,427,000 |
| Expenses | ||
| Interest Expense | $6,354,000 | $12,925,000 |
| Total Expenses | $607,571,000 | $500,126,000 |
| Other Income Expense | $-42,844,000 | $93,119,000 |
| Other Non Operating Income Expenses | $-32,786,000 | $11,576,000 |
| Net Non Operating Interest Income Expense | $-1,453,000 | $-12,715,000 |
| Interest Expense Non Operating | $6,354,000 | $12,925,000 |
| Operating Expense | $327,974,000 | $205,145,000 |
| Income & Earnings | ||
| Net Income From Continuing Operation Net Minority Interest | $-20,044,000 | $127,778,000 |
| Net Interest Income | $-1,453,000 | $-12,715,000 |
| Interest Income | $4,901,000 | $210,000 |
| Normalized Income | $-13,001,150 | $63,151,340 |
| Net Income From Continuing And Discontinued Operation | $-86,462,000 | $139,565,000 |
| Total Operating Income As Reported | $-27,103,000 | $76,769,000 |
| Net Income Common Stockholders | $-86,462,000 | $139,565,000 |
| Net Income | $-86,462,000 | $139,565,000 |
| Net Income Including Noncontrolling Interests | $-86,462,000 | $139,565,000 |
| Net Income Discontinuous Operations | $-66,418,000 | $11,787,000 |
| Net Income Continuous Operations | $-20,044,000 | $127,778,000 |
| Pretax Income | $-63,851,000 | $157,705,000 |
| Special Income Charges | $-15,124,000 | $4,330,000 |
| Earnings From Equity Interest | $-1,143,000 | $1,757,000 |
| Interest Income Non Operating | $4,901,000 | $210,000 |
| Operating Income | $-19,554,000 | $77,301,000 |
| Depreciation Amortization Depletion Income Statement | $60,884,000 | $9,282,000 |
| Depreciation And Amortization In Income Statement | $60,884,000 | $9,282,000 |
| Amortization Of Intangibles Income Statement | $60,884,000 | $9,282,000 |
| Gross Profit | $308,420,000 | $282,446,000 |
| Per Share | ||
| Diluted EPS | - | $0.97 |
| Basic EPS | - | $1.03 |
| Other | ||
| Tax Effect Of Unusual Items | $-1,872,150 | $15,159,340 |
| Tax Rate For Calcs | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $67,339,000 | $163,619,000 |
| Total Unusual Items | $-8,915,000 | $79,786,000 |
| Total Unusual Items Excluding Goodwill | $-8,915,000 | $79,786,000 |
| Reconciled Depreciation | $115,921,000 | $72,775,000 |
| EBITDA (Bullshit earnings) | $58,424,000 | $243,405,000 |
| EBIT | $-57,497,000 | $170,630,000 |
| Diluted NI Availto Com Stockholders | $-86,462,000 | $139,565,000 |
| Tax Provision | $-43,807,000 | $29,927,000 |
| Gain On Sale Of Ppe | $0 | $1,647,000 |
| Gain On Sale Of Business | $0 | $8,370,000 |
| Write Off | $15,124,000 | $5,687,000 |
| Gain On Sale Of Security | $6,209,000 | $75,456,000 |
| Amortization | $60,884,000 | $9,282,000 |
| Research And Development | $97,889,000 | $84,103,000 |
| Selling General And Administration | $169,201,000 | $111,760,000 |
| Diluted Average Shares | - | $138,700,000 |
| Basic Average Shares | - | $130,100,000 |
| Minority Interests | - | $0 |
| Impairment Of Capital Assets | - | $0 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2022-12-31 | 2021-12-31 |
|---|---|---|
| Assets | ||
| Net Tangible Assets | $320,457,000 | $631,193,000 |
| Total Assets | $1,504,722,000 | $2,311,025,000 |
| Total Non Current Assets | $825,074,000 | $1,661,812,000 |
| Other Non Current Assets | $1,159,000 | $826,039,000 |
| Non Current Prepaid Assets | $10,104,000 | $13,829,000 |
| Non Current Deferred Assets | $37,189,000 | $0 |
| Non Current Deferred Taxes Assets | $37,189,000 | $0 |
| Investmentin Financial Assets | $58,135,000 | $56,698,000 |
| Goodwill And Other Intangible Assets | $697,048,000 | $729,187,000 |
| Other Intangible Assets | $164,408,000 | $230,831,000 |
| Current Assets | $679,648,000 | $649,213,000 |
| Other Current Assets | $208,000 | $546,000 |
| Assets Held For Sale Current | $0 | $277,633,000 |
| Restricted Cash | $1,307,000 | $1,308,000 |
| Prepaid Assets | $55,823,000 | $51,207,000 |
| Receivables | $175,717,000 | $184,861,000 |
| Other Receivables | $56,570,000 | $65,165,000 |
| Accounts Receivable | $119,147,000 | $119,696,000 |
| Allowance For Doubtful Accounts Receivable | $-22,743,000 | $-21,621,000 |
| Gross Accounts Receivable | $141,890,000 | $141,317,000 |
| Cash Cash Equivalents And Short Term Investments | $446,593,000 | $133,658,000 |
| Cash And Cash Equivalents | $446,593,000 | $133,658,000 |
| Non Current Accounts Receivable | - | $56,797,000 |
| Taxes Receivable | - | $0 |
| Debt | ||
| Total Debt | $219,443,000 | $372,949,000 |
| Long Term Debt And Capital Lease Obligation | $212,835,000 | $366,816,000 |
| Long Term Debt | $200,395,000 | $350,062,000 |
| Current Debt And Capital Lease Obligation | $6,608,000 | $6,133,000 |
| Net Debt | - | $216,404,000 |
| Liabilities | ||
| Total Liabilities Net Minority Interest | $487,217,000 | $950,645,000 |
| Total Non Current Liabilities Net Minority Interest | $256,904,000 | $462,221,000 |
| Other Non Current Liabilities | $44,069,000 | $33,824,000 |
| Liabilities Heldfor Sale Non Current | $0 | $42,707,000 |
| Non Current Deferred Liabilities | $0 | $18,874,000 |
| Non Current Deferred Taxes Liabilities | $0 | $18,688,000 |
| Current Liabilities | $230,313,000 | $488,424,000 |
| Current Deferred Liabilities | $90,098,000 | $87,889,000 |
| Payables And Accrued Expenses | $97,668,000 | $65,067,000 |
| Payables | $34,849,000 | $6,197,000 |
| Total Tax Payable | $4,008,000 | $4,023,000 |
| Accounts Payable | $30,841,000 | $2,174,000 |
| Other Current Liabilities | - | $298,986,000 |
| Equity | ||
| Common Stock Equity | $1,017,505,000 | $1,360,380,000 |
| Total Equity Gross Minority Interest | $1,017,505,000 | $1,360,380,000 |
| Stockholders Equity | $1,017,505,000 | $1,360,380,000 |
| Gains Losses Not Affecting Retained Earnings | $-74,000 | $-2,762,000 |
| Retained Earnings | $645,810,000 | $719,795,000 |
| Other | ||
| Treasury Shares Number | $173,480,000 | $160,591,000 |
| Ordinary Shares Number | $106,071,000 | $116,114,000 |
| Share Issued | $279,551,000 | $276,705,000 |
| Tangible Book Value | $320,457,000 | $631,193,000 |
| Invested Capital | $1,217,900,000 | $1,710,442,000 |
| Working Capital | $449,335,000 | $160,789,000 |
| Capital Lease Obligations | $19,048,000 | $22,887,000 |
| Total Capitalization | $1,217,900,000 | $1,710,442,000 |
| Treasury Stock | $1,556,230,000 | $1,321,805,000 |
| Additional Paid In Capital | $1,925,205,000 | $1,962,386,000 |
| Capital Stock | $2,794,000 | $2,766,000 |
| Common Stock | $2,794,000 | $2,766,000 |
| Non Current Deferred Revenue | $0 | $186,000 |
| Long Term Capital Lease Obligation | $12,440,000 | $16,754,000 |
| Current Deferred Revenue | $90,098,000 | $87,889,000 |
| Current Capital Lease Obligation | $6,608,000 | $6,133,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $35,939,000 | $30,349,000 |
| Current Accrued Expenses | $62,819,000 | $58,870,000 |
| Investments And Advances | $58,135,000 | $56,698,000 |
| Available For Sale Securities | $58,135,000 | $56,698,000 |
| Goodwill | $532,640,000 | $498,356,000 |
| Net PPE | $21,439,000 | $36,059,000 |
| Accumulated Depreciation | $-154,636,000 | $-210,872,000 |
| Gross PPE | $176,075,000 | $246,931,000 |
| Leases | $14,438,000 | $14,438,000 |
| Other Properties | $11,979,000 | $18,324,000 |
| Machinery Furniture Equipment | $149,658,000 | $214,169,000 |
| Properties | $0 | $0 |
| Preferred Stock | - | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2022-12-31 | 2021-12-31 |
|---|---|---|
| Free Cash Flow | ||
| Free Cash Flow | $83,296,000 | $-118,001,000 |
| Operating Activities | ||
| Operating Cash Flow | $115,562,000 | $-76,616,000 |
| Cash From Discontinued Operating Activities | $-23,257,000 | $-190,313,000 |
| Cash Flow From Continuing Operating Activities | $138,819,000 | $113,697,000 |
| Operating Gains Losses | $1,143,000 | $-10,127,000 |
| Investing Activities | ||
| Capital Expenditure | $-32,266,000 | $-41,385,000 |
| Investing Cash Flow | $585,146,000 | $-12,696,000 |
| Cash From Discontinued Investing Activities | $-13,138,000 | $-37,696,000 |
| Cash Flow From Continuing Investing Activities | $598,284,000 | $25,000,000 |
| Capital Expenditure Reported | $-32,266,000 | $-41,385,000 |
| Financing Activities | ||
| Repurchase Of Capital Stock | $-234,425,000 | $-417,443,000 |
| Financing Cash Flow | $-444,911,000 | $-258,866,000 |
| Cash Flow From Continuing Financing Activities | $-444,911,000 | $-258,866,000 |
| Net Other Financing Charges | $-32,129,000 | $-16,423,000 |
| Net Common Stock Issuance | $-234,425,000 | $-417,443,000 |
| Other | ||
| Repayment Of Debt | $-200,000,000 | $-75,000,000 |
| Issuance Of Debt | $21,643,000 | $250,000,000 |
| End Cash Position | $447,900,000 | $191,651,000 |
| Beginning Cash Position | $191,651,000 | $539,801,000 |
| Effect Of Exchange Rate Changes | $452,000 | $28,000 |
| Changes In Cash | $255,797,000 | $-348,178,000 |
| Common Stock Payments | $-234,425,000 | $-417,443,000 |
| Net Issuance Payments Of Debt | $-178,357,000 | $175,000,000 |
| Net Long Term Debt Issuance | $-178,357,000 | $175,000,000 |
| Long Term Debt Payments | $-200,000,000 | $-75,000,000 |
| Long Term Debt Issuance | $21,643,000 | $250,000,000 |
| Net Investment Purchase And Sale | $-9,933,000 | $-2,421,000 |
| Purchase Of Investment | $-9,933,000 | $-2,421,000 |
| Net Business Purchase And Sale | $640,483,000 | $68,806,000 |
| Sale Of Business | $672,471,000 | $68,806,000 |
| Purchase Of Business | $-31,988,000 | $0 |
| Change In Working Capital | $23,570,000 | $-18,276,000 |
| Change In Other Working Capital | $7,677,000 | $-37,981,000 |
| Change In Other Current Liabilities | $10,246,000 | $1,329,000 |
| Change In Other Current Assets | $-4,489,000 | $1,742,000 |
| Change In Payables And Accrued Expense | $1,363,000 | $-15,313,000 |
| Change In Accrued Expense | $-26,507,000 | $-5,240,000 |
| Change In Payable | $27,870,000 | $-10,073,000 |
| Change In Account Payable | $27,870,000 | $-10,073,000 |
| Change In Prepaid Assets | $-776,000 | $32,204,000 |
| Change In Receivables | $9,549,000 | $-257,000 |
| Other Non Cash Items | $100,283,000 | $-88,237,000 |
| Stock Based Compensation | $25,117,000 | $11,808,000 |
| Asset Impairment Charge | $15,124,000 | $5,687,000 |
| Deferred Tax | $-55,877,000 | $502,000 |
| Deferred Income Tax | $-55,877,000 | $502,000 |
| Depreciation Amortization Depletion | $115,921,000 | $72,775,000 |
| Depreciation And Amortization | $115,921,000 | $72,775,000 |
| Earnings Losses From Equity Investments | $1,143,000 | $-1,757,000 |
| Gain Loss On Sale Of Business | $0 | $-8,370,000 |
| Net Income From Continuing Operations | $-86,462,000 | $139,565,000 |
| Net Short Term Debt Issuance | - | $-75,000,000 |
| Short Term Debt Payments | - | $-75,000,000 |
| Short Term Debt Issuance | - | $250,000,000 |
Fetched: 2026-02-02